Trial Profile
A Phase I Study to Determine the Safety and Pharmacokinetic Study of Tafetinib in Patients With Advanced Solid Tumors
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 08 Mar 2018
Price :
$35
*
At a glance
- Drugs Tafetinib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Nanjing Yoko Biomedical
- 11 Apr 2016 New trial record